Cysteinyl protease inhibitors
US6617426B1 · kind B1 · utility
2Cited by
1References
19Claims
0Family size
Inventors
Key dates
| Filing date | Jun 22, 1999 |
| Grant date | Sep 9, 2003 |
| Priority date | — |
| Expiry date | Jun 22, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Amino acid di- and tri-peptide analogs having C-terminal vinylic groups, pharmaceutical compositions containing the analogs and methods of treating diseases using cysteinyl protease inhibitors; particularly neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.